PharmiWeb.com - Global Pharma News & Resources
20-Oct-2023

Point Of Care Blood Testing Devices Industry is on track to achieve a valuation of US$ 49,973.6 Million by 2032 | FMI

By 2032, the Point of care blood testing devices industry Size is anticipated to be worth US$ 49,973.6 million, up from US$ 15,362.4 million in 2022, growing at a CAGR of 11.3%.

Point of care or POC blood testing devices are easy handheld devices which are used to perform various blood tests. Point of care blood testing devices are used to obtain diagnostics test such as protein test, blood metabolites test, hormone blood test, INR or prothrombin test (PT), haemoglobin test and also used to test glucose level in blood. Point of care blood testing devices also referred by many different names such as remote testing device, near-patient testing device and rapid diagnostics devices.

Request A Report Sample To Gain Comprehensive Insights! https://www.futuremarketinsights.com/ask-question/rep-gb-5142

It can be deduced from the current situations brought about by the pandemic that the production, and supply chain activities have experienced minor hurdles. However, the market is projected to gradually recover post-COVID-19, which will present attractive opportunities for sales across various regions of the world in the following years.

Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Point of care blood testing devices industry. The study features insights on the current growth dynamics and the major revenue reforms prevailing in the market as along with the key takeaways over the forecast.

The team of analysts at Future Market Insights are focussing on research and market study to produce different Point of care blood testing devices industry forecasts and predictions at both national and international levels. They have considered several leads of information pertaining to the industry like market figures and merger estimations to assess and produce reliable and informative insights on the Point of care blood testing devices industry.

Key Takeaways:

  • The POC blood testing devices market is expected to witness significant growth in the coming years, driven by the increasing prevalence of chronic diseases, rising demand for convenient and timely testing, and technological advancements.
  • North America is expected to remain the largest market for POC blood testing devices, followed by Europe and Asia Pacific.
  • The blood glucose testing segment is expected to account for the largest share of the market during the forecast period, followed by the coagulation testing segment.
  • The key players in the POC blood testing devices market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Danaher Corporation.

Feel Free To Connect With Our Analyst For Any Doubts Or Concerns You May Have! https://www.futuremarketinsights.com/ask-question/rep-gb-5142

Market trends:

  • The POC blood testing devices market is witnessing a growing trend of miniaturization and integration, which is leading to the development of smaller, more portable, and easier-to-use devices.
  • There is also a growing trend of connectivity in the POC blood testing devices market, with many devices now being able to connect to smartphones and other devices for data sharing and analysis.
  • The increasing adoption of telemedicine is also driving the growth of the POC blood testing devices market, as these devices can be used to remotely monitor patients’ health conditions.

Future outlook:

The POC blood testing devices market is expected to continue to grow in the coming years, driven by the increasing prevalence of chronic diseases, rising demand for convenient and timely testing, and technological advancements. The development of new POC blood testing devices for a wider range of diseases is also expected to boost the growth of the market.

Key Segments in the Point of care blood testing devices industry:

By Product Type:

  • Diabete POC Analyzer
  • Coaglulation POC Analyzer
  • POC Blood Analyzer
  • Hematology POC Reader

By Technology:

  • Printer Devices
  • Touch-Screen Devices
  • Hand-held Devices

By Distribution Channels:

  • Retail Prices
  • Hospitals
  • Clinics
  • Health Centers
  • Homecare Settings

Customization Unleashed: Learn How to Stand Out in a Competitive Landscape! https://www.futuremarketinsights.com/customization-available/rep-gb-5142

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Editor Details

Last Updated: 20-Oct-2023